Plasmin

Oct 25, 2018

Prometic announces second annual Plasminogen Deficiency Awareness Week

Oct 16, 2018

Prometic announces positive feedback from FDA Type-C meeting on Ryplazim(TM) (plasminogen) BLA

Dec 06, 2017

Pivotal Data for Prometic's Intravenous Plasminogen Replacement Therapy to Be Presented at American Society for Hematology

Nov 02, 2017

For the First Time Ever, There Will be a Full Week Dedicated to Plasminogen Deficiency (PLGD) !

Oct 26, 2017

Prometic receives clearance from the Swedish Medical Products Agency to initiate plasminogen diabetic foot ulcer Phase 2 clinical trial

Oct 19, 2017

Prometic Receives Priority Review Status From Health Canada for Plasminogen (Ryplazim(TM))

Oct 13, 2017

Prometic Announces FDA Acceptance of its Biologics License Application for Plasminogen (Ryplazim(TM))

Aug 29, 2017

Prometic Receives Rare Pediatric Disease Designation From U.S. FDA for its Plasminogen Replacement Therapy